Goldman Sachs’s Kodiak Sciences KOD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $90.2M | Buy |
2,316,014
+627,011
| +37% | +$24.4M | 0.01% | 1298 |
|
|
2026
Q1 | $64.4M | Buy |
1,689,003
+385,973
| +30% | +$9.97M | 0.01% | 1369 |
|
|
2025
Q4 | $36.4M | Buy |
1,303,030
+976,254
| +299% | +$20M | ﹤0.01% | 1774 |
|
|
2025
Q3 | $5.35M | Buy |
326,776
+127,765
| +64% | +$1.1M | ﹤0.01% | 3573 |
|
|
2025
Q2 | $742K | Sell |
199,011
-50,705
| -20% | -$180K | ﹤0.01% | 4909 |
|
|
2025
Q1 | $700K | Sell |
249,716
-22,537
| -8% | -$123K | ﹤0.01% | 4960 |
|
|
2024
Q4 | $2.71M | Sell |
272,253
-46,544
| -15% | -$268K | ﹤0.01% | 4030 |
|
|
2024
Q3 | $832K | Buy |
318,797
+568
| +0.2% | +$1.51K | ﹤0.01% | 4762 |
|
|
2024
Q2 | $748K | Sell |
318,229
-34,251
| -10% | -$116K | ﹤0.01% | 4596 |
|
|
2024
Q1 | $1.85M | Sell |
352,480
-41,040
| -10% | -$201K | ﹤0.01% | 3921 |
|
|
2023
Q4 | $1.2M | Sell |
393,520
-41,573
| -10% | -$92.5K | ﹤0.01% | 4279 |
|
|
2023
Q3 | $783K | Sell |
435,093
-70,504
| -14% | -$249K | ﹤0.01% | 4413 |
|
|
2023
Q2 | $3.49M | Buy |
505,597
+103,052
| +26% | +$630K | ﹤0.01% | 3421 |
|
|
2023
Q1 | $2.5M | Sell |
402,545
-25,516
| -6% | -$179K | ﹤0.01% | 3693 |
|
|
2022
Q4 | $3.06M | Sell |
428,061
-37,634
| -8% | -$270K | ﹤0.01% | 3595 |
|
|
2022
Q3 | $3.6M | Buy |
465,695
+208,327
| +81% | +$2.02M | ﹤0.01% | 3438 |
|
|
2022
Q2 | $1.97M | Sell |
257,368
-248,917
| -49% | -$1.75M | ﹤0.01% | 4071 |
|
|
2022
Q1 | $3.91M | Buy |
506,285
+169,130
| +50% | +$6.6M | ﹤0.01% | 3581 |
|
|
2021
Q4 | $28.6M | Sell |
337,155
-65,060
| -16% | -$6.62M | 0.01% | 1807 |
|
|
2021
Q3 | $38.6M | Buy |
402,215
+83,359
| +26% | +$7.7M | 0.01% | 1488 |
|
|
2021
Q2 | $29.7M | Sell |
318,856
-4,592
| -1% | -$441K | 0.01% | 1708 |
|
|
2021
Q1 | $36.7M | Buy |
323,448
+37,635
| +13% | +$5.14M | 0.01% | 1417 |
|
|
2020
Q4 | $42M | Buy |
285,813
+151,295
| +112% | +$16.9M | 0.01% | 1260 |
|
|
2020
Q3 | $7.96M | Buy |
134,518
+5,209
| +4% | +$261K | ﹤0.01% | 2517 |
|
|
2020
Q2 | $7M | Buy |
129,309
+25,985
| +25% | +$1.47M | ﹤0.01% | 2539 |
|
|
2020
Q1 | $4.93M | Buy |
103,324
+6,231
| +6% | +$374K | ﹤0.01% | 2660 |
|
|
2019
Q4 | $6.99M | Buy |
97,093
+65,277
| +205% | +$2.37M | ﹤0.01% | 2701 |
|
|
2019
Q3 | $458K | Sell |
31,816
-9,123
| -22% | -$119K | ﹤0.01% | 4494 |
|
|
2019
Q2 | $479K | Buy |
40,939
+29,639
| +262% | +$264K | ﹤0.01% | 4420 |
|
|
2019
Q1 | $74K | Sell |
11,300
-76,652
| -87% | -$567K | ﹤0.01% | 4970 |
|
|
2018
Q4 | $624K | Buy |
+87,952
| New | +$779K | ﹤0.01% | 4240 |
|
Other funds holding KOD
BBA
B
JT
RI
BCM
Goldman Sachs's KOD Position: Q2 2026 in Review
Goldman Sachs increased its Kodiak Sciences (KOD) stake by 37% in Q2 2026, buying an estimated $24.4M and bringing the position to 2,316,014 shares worth $90.2M. The position accounts for 0.01% of the portfolio, ranked #1298.
Goldman Sachs first reported a position in KOD in Q4 2018 and has held it in 31 quarters since. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.
- Goldman Sachs held 2,316,014 shares of Kodiak Sciences worth $90.2M as of Q2 2026.
- Goldman Sachs bought 627,011 Kodiak Sciences shares in Q2 2026, an estimated $24.4M.
- Kodiak Sciences made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1298 holding.
- Goldman Sachs first reported a position in Kodiak Sciences in Q4 2018 and has held it in 31 quarters since.
- 200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.